Getty ImagesTreating failing eyesight and high cholesterol are two new ways to lower the risk of dementia developing, a major report suggests.

Stacey AgnewA two-year-old girl fell unconscious and had to be hospitalised after drinking a Slush Puppie.

The parents of a young woman who died during a legal battle with the NHS have won their appeal over a ruling their daughter could not make decisions over her care.

Vicky BoydFor those with severe weight issues, semaglutide – the active ingredient in slimming drugs – can be a life-changer. Celebrity success stories have massively increased demand, but brought with it a booming black market for illegal and often life-threatening products. BBC Investigations has discovered how easy these are to buy.

Getty ImagesThere are 1,594 people in Welsh hospitals who are fit to leave but remain there because of care or assessment delays, figures for the last year show.

PAChancellor Rachel Reeves’s decision to scrap planned changes to the care system in England has been described as a “tragedy” by Sir Andrew Dilnot, the man who authored the proposals in 2011.

PA MediaThe government and the BMA trade union are expected to confirm they have struck an improved pay deal for junior doctors in England worth 22% on average over two years.

A ban on puberty blockers introduced by the previous government using emergency legislation was lawful, the High Court has ruled.

While not a perfect alternative to colonoscopies or fecal tests, experts hope the test could lead to more people getting screened for colorectal cancers.The Food and Drug Administration on Monday approved a new screening test for colorectal cancer. It requires only a sample of blood and can find cancers when they are early stage and usually curable.For many people, a routine blood test is easier to get than a colonoscopy or a fecal sample test. But the blood test, made by Guardant Health of Palo Alto, Calif., comes with a limitation. Unlike other screening tests for colon and rectal cancers, it has a poor record of finding precancerous growths. Removal of those growths can prevent cancer.The test, named Shield, will be available within a week. Guardant will announce its list price at that time, said Matt Burns, a company spokesman. It is approved for people aged 45 and over who are at average risk for colon cancer.The hope is that the blood test, despite its limitation, can encourage more people to be screened for colorectal cancer, the second-most common cause of cancer-related deaths in the United States. As many as 53,000 Americans are expected to die from colorectal cancer this year.Regular screening can prevent as many as 73 percent of those deaths. But although current guidelines recommend screenings starting at age 45, as many as 25 to 50 percent of people who should be getting screened are not.The problem is convincing more people to be screened. That is where the new test comes in. It is simple for patients — the blood sample can be obtained at a doctor’s office as part of a routine physical exam, or at a commercial lab.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe.

Yellow heat health warnings have been issued across much of England with forecasts saying temperatures may climb to as high as 32C (90F) on Tuesday.